The present research aimed to characterize the potential efficiency of two chelators after cadmium administration for 60 days following two dose levels of 20 and 40 mg/kg body weight daily to male rats. However, the hypothesis that the two chelators might be more efficient as combined therapy than as single therapy in removing cadmium from the body was considered. In this way, two known chelators deferasirox and deferiprone (L1) were chosen and tested in the acute rat model. Two chelators were given orally as a single or combined therapy for the period of a week. Cadmium and iron concentrations in various tissues were determined by graphite furnace and flame atomic absorption spectrometry methods, respectively. The combined chelation therapy results show that Deferasirox and L1 are able to remove cadmium ions from the body while iron concentration returned to the normal level and symptoms are also decreased.
Akesson A., Lundh T., Vahter M., Bjellerup P., Lidfeldt J., and Nerbrand C. ( 2005) Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environmental Health Perspectives113: 1627-1631.
2.
Amiri A., Fatemi SJ, and Fatemi SN ( 2007) Removal of Thallium by combining desferrioxamine and deferiprone chelators in rats. Biometals20: 159-163.
3.
Cappellini MD ( 2008) Long-term efficacy and safety of deferasirox. Blood Review2: 35-41.
4.
Clarke ET and Martell AE ( 1992) Stabilities of 1, 2-dimethyl-3-hydroxypyrid-4-one chelates of divalent and trivalent metal ions. Inorganica Chimica Acta19: 57-63.
5.
Dalhamn T. and Friberg L. ( 1955) Dimercaprol (2, 3-dimercaptopropanol) in chronic cadmium poisoning. Acta Pharmacology et Toxicologica11(1): 68-71.
6.
Fatemi SJ, Amiri A., Bazargan MH, Tubafard S., and Fatemi SN ( 2007) Clinical evaluation of desferrioxamine (DFO) for removal of thallium ions in rat. International Journal of Artificial Organs30: 902-905.
7.
Fatemi SJ, Tubafard S., and Nadi B. ( 2009) Evaluation of the effect of cadmium on rat organs and investigation of diethyl carbamate as an oral drug in treatment of cadmium toxicity. Medicinal Chemistry Research18: 179-186.
8.
Flora SJS, Bhattacharyan R., and Vijayaraghavan R. (1995) Combined therapeutic potential of mesodimercaptosuccinic acid and calcium edentate on the mobilization and distribution of lead in experimental lead intoxication in rats. Fundamental and Applied Toxicology25: 233-240.
9.
Gomez W., Esparza JL, Domingo JL, Singha PK, and Jones MM ( 1988) Comparative aluminium mobilizing action of desferrioxamine and four 3-hydroxypyrid-4-ones in aluminium-loaded rats. Toxicology130: 175-181.
10.
Hassler CS and Wilkinson KJ ( 2003) Failure of the biotic ligand and free-ion activity models to explain zinc bioaccumulation by Chlorella kesslerii. Toxicological and Environmental Chemistry22: 620-626.
11.
Heinz U., Hegetschweiler K., Acklin P., Faller B., Lattmann R., and Schnebli HP ( 1999) 4-[3,5-Bis (2-hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid: a novel, efficient and selective iron (iii) complexing agent. Angewandte Chemie International Edition38: 2568-2571.
12.
Henkel G. and Krebs B. ( 2004) Metallothioneins: zinc, cadmium, mercury, and copper thiolates and selenolates mimicking protein active site features structural aspects and biological implications. Chemistry Review104: 801-824.
13.
Huang HQ, Cao TM, and Lin QM ( 2004) Characteristics of trapping copper iron with scrolled ferritin reactor in the flowing seawater. Environmental Science and Technology38: 2476-2481.
14.
Ivanoviene L., Staneviciene I., Lesaukaite V., Sadauskiene I., and Ivanov L. ( 2004) Activities of tRNALeu and Leucyl tRNA synthetase and programmed cell death in the liver of mice under experimental cadmium poisoning. Journal of Trace Elements and Electrolytes21: 180-184.
15.
Jones MM and Cherian MG ( 1990) The search for chelate antagonists for chronic cadmium intoxication. Toxicology62(1):1-25.
16.
Kaur G., Srivastava UC, Dwivedi RS, and Srivastava RC ( 1984) Influence of polyaminocarboxylic acids on the removal of manganese-54 from the body organs of sham-operated and partially hepatectomized rats. Toxicology Letters22: 1-6.
17.
Kontoghiorghes GJ and Sheppard L. ( 1987) Simple synthesis of the potent chelators l-alkyl-3-hydroxy -2-mehylpyrid-4-ones. Inorganica Chimica Acta136: 111-112.
18.
Lifton RP, Gharavi AG, and Geller DS ( 2001) Molecular mechanisms of human hypertension. Cell104: 545-556.
19.
Miao AJ, Wang WX, and Juneau P. ( 2005) Comparison of Cd, Cu, and Zn toxic effects on four marine phytoplankton by pulse-amplitude-modulated fluorometry. Environmental Toxicology and Chemistry24: 2603-2611.
20.
Mirimanoff N. and Wilkinson KJ ( 2000) Regulation of Zn accumulation by a freshwater gram-positive bacterium (Rhodococcus opacus). Environmental Science and Technology34: 616-622.
21.
Neufeld EJ ( 2006) Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions . Blood107(9): 3436-3441.
22.
Nisbet-Brown E., Olivieri NF, Giardina PJ, Grady RW, Neufeld EJ, Sechaud R., et al. (2003) Effectiveness and safety of Icl670 in iron-loaded patients with thalassaemia: a placebo-controlled, dose-escalation trial. Lancet361: 1597-1602.
23.
Satarug S., Nishijo M., Lasker JM, Edwards RJ, and Moore MR ( 2006) Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases?The Tohoku Journal of Experimental Medicine208: 179-202.
24.
Satarug S., Nishijo M., Ujjin P., Vanavanitkun Y., and Moore MR ( 2005) Cadmium-induced nephropathy in the development of high blood pressure. Toxicology Letters157: 57-68.
25.
Shimoda R., Nagamine T., Takagi H., Mori M., and Waalkes MP ( 2001) Induction of apoptosis in cells by cadmium: quantitative negative correlation between basal or induced metallothionein concentration and apoptotic rate. Toxicology Science64: 208-215.
26.
Shokooh Saljooghi A. and Fatemi SJ(2010a) Cadmium transport in blood serum. Toxicology and Industrial Health26: 195-201.
27.
Shokooh Saljooghi A. and Fatemi SJ(2010b) Clinical evaluation of Deferasirox for removal of cadmium ions in rat. Biometals23: 707-712.
28.
Shokooh Saljooghi A. and Fatemi SJ ( 2010c) Removal of Thallium by Deferasirox in rats as biological model. Journal of Applied Toxicology. In press.
29.
Steinhauser S., Heinz U., Bartholomä M., Weyhermüller T., Nick H., and Hegetschweiler K. (2004) Complex formation of ICL670 and related ligands with FeIII and FeII. Europian Journal of Inorgorganic Chemistry21: 4177-4192.
30.
Tubafard S. and Fatemi SJ ( 2008) Chelation of bismuth by combining desferrioxamine and deferiprone in rats. Toxicology and Industrial Health24: 235-240.
31.
Tubafard S., Fatemi SJ, Shokooh Saljooghi A., and Torkzadeh M. ( 2010) Removal of vanadium by combining desferrioxamine and deferiprone chelators in rats. Medicinal Chemistry Research . In press.
32.
Waisberg M., Joseph P., Hale B., and Beyersmann D. ( 2003) Molecular and cellular mechanisms of cadmium carcinogenesis . Toxicology192: 95-117.
33.
Wilde KL, Stauber JL, Markich SJ, Franklin NM, and Brown PL ( 2006) The effect of pH on the uptake and toxicity of copper and zinc in a tropical freshwater alga (Chlorella sp.). Archives of Environmental Contamination and Toxicology51: 174-185.
34.
Wood JC, Otto-Duessel M., Gonzalez I., Aguilar MI, Shimada H., Nick H., et al. (2006) Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil. Translational Research148(5): 272-280.
35.
Yang LPH, Keam SJ, and Keating GM ( 2007) Deferasirox: a review of its use in the management of transfusional chronic iron overload. Drugs67: 2211-2230.
